Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions

被引:23
|
作者
Bates, GP [1 ]
Davies, SW [1 ]
机构
[1] UNIV LONDON UNIV COLL,DEPT ANAT & DEV BIOL,LONDON WC1E 6BT,ENGLAND
来源
MOLECULAR MEDICINE TODAY | 1997年 / 3卷 / 11期
关键词
D O I
10.1016/S1357-4310(97)01142-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CAG/polyglutamine expansion is the mutational mechanism that causes a number of late-onset neurodegenerative diseases, Expanded CAG repeats are unstable: they vary in size between tissues and change in site upon transmission from parent to offspring, These mutations are thought to impart a dominant gain of function to the proteins in which they are located. Recent reports describing the first mouse models of these diseases promise to shed light on the molecular mechanisms underlying CAG-repeat instability, the pathways by which polyglutamine expansion causes cell death and the factors that determine the specificity of the neurodegeneration.
引用
收藏
页码:508 / 515
页数:8
相关论文
共 50 条
  • [1] Inherited neurodegenerative disorders caused by CAG/polyglutamine tract expansions: Symposium introduction
    LaSpada, AR
    Clark, AW
    BRAIN PATHOLOGY, 1997, 7 (03) : 877 - 880
  • [2] Polyglutamine expansions and neurodegenerative diseases
    Saudou, F
    Devys, D
    Trottier, Y
    Imbert, G
    Stoeckel, ME
    Brice, A
    Mandel, JL
    GENETIC AND PSYCHIATRIC DISORDERS, 1998, 69 : 261 - 277
  • [3] Polyglutamine expansions and neurodegenerative diseases
    Saudou, F
    Devys, D
    Trottier, Y
    Imbert, G
    Stoeckel, ME
    Brice, A
    Mandel, JL
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1996, 61 : 639 - 647
  • [4] Neurodegenerative tauopathies: Human disease and transgenic mouse models
    Lee, VMY
    Trojanowski, JQ
    NEURON, 1999, 24 (03) : 507 - 510
  • [5] Issues in establishing transgenic mouse models of neurodegenerative disease
    Games, D
    Barbour, R
    Grajeda, H
    Guido, T
    Johnson-Wood, K
    Khan, K
    Soriano, F
    Seubert, P
    Schenk, D
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 441 - 441
  • [6] Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
    Jankowsky J.L.
    Savonenko A.
    Schilling G.
    Wang J.
    Xu G.
    Borchelt D.R.
    Current Neurology and Neuroscience Reports, 2002, 2 (5) : 457 - 464
  • [7] Spinocerebellar ataxias caused by polyglutamine expansions
    Stevanin, G
    Dürr, A
    Brice, A
    TRIPLE REPEAT DISEASES OF THE NERVOUS SYSTEMS, 2002, 516 : 47 - 77
  • [8] Inflammation in transgenic mouse models of neurodegenerative disorders
    Schwab, Claudia
    Klegeris, Andis
    McGeer, Patrick. L.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (10): : 889 - 902
  • [9] Transgenic mouse models and human neurodegenerative disorders
    Deng, HX
    Siddique, T
    ARCHIVES OF NEUROLOGY, 2000, 57 (12) : 1695 - 1702
  • [10] Transgenic Mouse Models for the Study of Neurodegenerative Diseases
    Marin-Moreno, Alba
    Canoyra, Sara
    Fernandez-Borges, Natalia
    Carlos Espinosa, Juan
    Maria Torres, Juan
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (01):